Celcuity Inc. (CELC): Cash & Equivalents
$165.70M
As of 2025-12-31
$182.05M
As of 2026-06-30
+88.9%
3-year compound annual growth
+70.1%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $165.70M | +636.0% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $22.52M | -26.6% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $30.66M | +24.8% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $24.57M | -70.8% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $84.29M | +624.2% | 2023-03-23, Balance as of period end |
| 2020-12-31 | $11.64M | -37.9% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $18.74M | +17.5% | 2021-02-16, Balance as of period end |
| 2018-12-31 | $15.94M | n/c | 2020-03-13, Balance as of period end |
| 2017-12-31 | $2.64M | -54.9% | 2019-03-01, Balance as of period end |
| 2016-12-31 | $5.86M | n/a | 2018-03-15, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Celcuity Inc. (CELC) | 2025-12-31 | $165.70M | +636.0% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $65.43M | -43.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $116.73M | -2.5% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $495.98M | +159.0% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $124.25M | +35.9% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $796.27M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $50.19M | -9.0% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $362.58M | +51.7% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $378.20M | -28.0% |
Compare CELC, CDNA, CSTL, BLLN side by side · Screen every company in Services-Medical Laboratories ↗